Position Papers and Guidelines

Below are all of ABCD’s position statements since year 2000. Some are dated and have been superseded but nevertheless they remain available as a record of the evolution of thinking in our speciality with time. It is the responsibility of the reader to ensure that any data that they use from these statements has not been superseded by new information / guidance.

Click the link on the left to see the position paper and on the right please find where the paper was published.

Year / Title Where published
2023  

Finerenone in the management of Diabetic Kidney Disease: A consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association

  
2021  

Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021) | RCP Journals

https://www.rcpjournals.org/content/clinmedicine/21/3/204

Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement

 https://bjd-abcd.com/index.php/bjd/article/view/711

ABCD position statement on risk stratification of adult patients with diabetes during COVID-19 pandemic

 https://bjd-abcd.com/index.php/bjd/article/view/703

ABCD and Renal Association Standards of Care for Glycaemic Assessment in People with Diabetes on Haemodialysis

 

ABCD and Renal Association Guidelines on the detection and management of diabetes post solid organ transplantation

ABCD and Renal Association Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease

2021 Update

 

ABCD and Renal Association Clinical practice guidelines for management of lipids in adults with diabetic kidney disease

2021 Update

 

ABCD and Renal Association Clinical practice guidelines for management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease

2021 Update

 
2020  
Post transplant related Diabetes -NEW guideline LAUNCH Summary document
ABCD position statement on standards of care for management of adults with type 1 diabetes  
Managing Frailty and Associated Comorbidities in Older Adults with Diabetes  
2019  
Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS) https://bjd-abcd.com/index.php/bjd/article/view/453
Use of SGLT-2 inhibitors in the treatment of type 1 diabetes https://bjd-abcd.com/index.php/bjd/article/view/447
2018  

Guideline on managing hyperglycaemia in kidney disease

As part of the ABCD Renal Association clinical specialty work programme we have now finalised our guidelines on managing hyperglycaemia in kidney disease - See Link Opposite . A summary of the full guidelines with audit standards and issues for future research will be appearing this month in the British Journal of Diabetes. Full Document Peter Winocour, Stephen C Bain,Tahseen A Chowdhury, Parijat De, Ana Pokrajac, Damian Fogarty, Andrew Frankel, Debasish Banerjee, Mona Wahba, Indranil Dasgupta.
2017  
Association of British Clinical Diabetologists and Renal Association clinical guidelines: Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease For a summary of recommendations click here. See also I Dasgupta, DBanerjee, TA Chowdhury, P De, M Wahba, S Bain, A Frankel, D Fogarty, A Pokrajac, PH Winocour. Br. J. Diabetes 2017:17:160-164
Association of British Clinical Diabetologists - Renal Association (ABCD-RA) Clinical Practice Guidelines for Management of Lipids in Adults with Diabetes Mellitus and Nephropathy and/or Chronic Kidney Disease See also PB Mark, PH Winocour, C Day. Br. J. Diabetes 2017;17:64-72. A data collection chart for audit of lipid management can be downloaded by clicking here.
2016  
ABCD position statement on the risk of diabetic ketoacidosis with the use of sodium-glucose cotransporter-2 inhibitors  
ABCD position statement on standards of care for management of adults with type 1 diabetes - this has been superseded by the 2017 version - see above  
2015  
Care coordination/ management for adults with type 1 diabetes - joint position statement with Diabetes UK  
2013  
ABCD position statement on GLP-1 based therapies and pancreatic damage - full statement Also published as:
REJ Ryder, JA McKnight, AD Blann, K Dhatariya, R Gregory, AM Robinson, S Rowles, P Sharp. PH Winocour, C Walton
Practical Diabetes 2013; 30(9): 388-391
ABCD position statement on GLP-1 based therapies and pancreatic damage - summary statement  
ABCD response to the Future Hospital Commission  
2012  
Type 1 diabetes and specialist care P Sharp and C Walton
Practical Diabetes  2012; 29(8): 1-2
2011  
Diabetes and end of life care S Rowles, A Kilvert, A Sinclair
Pract Diab Int 2011; 28(1): 26-27
2010  
Recommendations following suspension of rosiglitazone (Avandia) N Goenka, A Roberts, S Rowles, REJ Ryder, PH Winocour
Pract Diab Int 2010; 27(9): 374-376a
Management of hypogonadal males with type 2 diabetes K Dhatariya, D Nagi, TH Jones
Pract Diab Int 2010; 27(9): 408-412
Haemoglobin A1c for the diagnosis of diabetes ES Kilpatrick and PH Winocour
Pract Diab Int 2010; 27(7): 306-310
Physical activity and exercise in diabetes D Nagi and I Gallen
Pract Diab Int 2010; 27(4): 158-163a
Continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care PJ Hammond, SA Amiel, CM Dayan, D Kerr, JC Pickup, JAM Shaw, FM Campbell, SA Greene and PC Hindmarsh
Pract Diab Int 2010; 27(2): 66-68
2009  
Incretin mimetics and DPP-4 inhibitors CMB Edwards and PH Winocour
Pract Diab Int 2009; 26(5): 191-194
Influenza Pandemic (including Swine Flu) and Diabetes K Shaw. Contingency planning and medical management : implications & implementation considerations for the UK. Published only on this website
2007  
Lipid modifying drug therapy in diabetes MD Feher and PH Winocour
Pract Diab Int 2007; 24(9): 458-462
Screening for gestational diabetes mellitus S Robinson and A Dornhorst
Pract Diab Int 2007; 24(4): 192-195
2006  
ABCD Diabetes Specialist Surveys P Winocour et al
Various places - see link
Insulin pumps P Hammond, S Boardman and RH Greenwood
Pract Diab Int 2006; 23(9): 235-400
Management of hyperglycaemic emergencies in adults MW Savage and A Kilvert
Pract Diab Int 2006; 23(5): 227-231
Diabetic ketoacidosis guideline updated in 2010 - see link
2005  
Joint Position Statement on Access to high quality care for people with diabetes - Diabetes UK and ABCD Association of British Clinical Diabetologists and Diabetes UK
ABCD website - see link
2004  
Diabetic retinal screening following publication of the NSF for England and Wales C Walton, A Kilvert, REJ Ryder, S Olcak, D Nagi and A Robinson
Pract Diab Int 2004; 21(9): 349-351
Glitazones ER Higgs, AJ Krentz
Pract Diab Int 2004; 21(8): 293-295
ABCD position papers: introduction RH Greenwood, K Shaw, Peter Winocour
Pract Diab Int 2004; 21(8): 293-293
Will NICE guidelines on the management of Type 2 diabetes improve diabetes care? PH Winocour, K Shaw, RH Greenwood
Pract Diab Int 2004; 21(1): 3-6
2002  
National Service Framework (NSF) Standards PH Winocour, RH Greenwood and J Wales
ABCD website - see link
General practitioners with a special interest in diabetes RH Greenwood
ABCD website - see link
2000  
ABCD Diabetes Specialist Surveys P Winocour et al
Various places - see link

ABCD Webinar Series

ABCD Webinars